Lacticaseibacillus rhamnosus LRa66: A Novel Probiotic for Blood Glucose and Lipid Reduction
Abstract
This study presents the discovery and application of Lacticaseibacillus rhamnosus LRa66, a novel probiotic strain exhibiting significant capabilities of blood glucose and lipid reduction. Isolated from human breast milk, LRa66 demonstrates superior tolerance to gastric acid, intestinal fluid, and bile salts. It has been shown to effectively ameliorate metabolic syndrome...
0 Comments
0 Shares
4243 Views